⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ANIX News
Anixa Biosciences, Inc.
Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization
prnewswire.com
ANIX
Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s
prnewswire.com
ANIX
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025
prnewswire.com
ANIX
Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic
prnewswire.com
ANIX
Breakthrough Discoveries Unlock $643B Cancer Treatment Market By 2034
prnewswire.com
GTBP
LXEO
ANIX
TEM
CTOR
GTBP
LXEO
ANIX
TEM
CTOR
Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
prnewswire.com
ANIX
Cleveland Clinic to Present Final Results of Phase 1 Clinical Trial for Anixa Biosciences' Breast Cancer Vaccine at 2025 San Antonio Breast Cancer Symposium
prnewswire.com
ANIX
Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals
prnewswire.com
ONCY
ANIX
ICCM
IBRX
REGN
ONCY
ANIX
ICCM
IBRX
REGN
Anixa Biosciences and Moffitt Cancer Center Complete Dosing of Fourth Cohort in Ovarian Cancer CAR-T Clinical Trial; Multiple Patients Surpassing Median Expected Survival
prnewswire.com
ANIX
Anixa Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
prnewswire.com
ANIX